Skip to main navigation Skip to search Skip to main content

Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies

  • Mala Pande
  • , Aron Joon
  • , Abenaa M. Brewster
  • , Wei V. Chen
  • , John L. Hopper
  • , Cathy Eng
  • , Sanjay Shete
  • , Graham Casey
  • , Fredrick Schumacher
  • , Yi Lin
  • , Tabitha A. Harrison
  • , Emily White
  • , Habibul Ahsan
  • , Irene L. Andrulis
  • , Alice S. Whittemore
  • , Esther M. John
  • , Aung Ko Win
  • , Enes Makalic
  • , Daniel F. Schmidt
  • , Miroslaw K. Kapuscinski
  • Heather M. Ochs-Balcom, Steven Gallinger, Mark A. Jenkins, Polly A. Newcomb, Noralane M. Lindor, Ulrike Peters, Christopher I. Amos, Patrick M. Lynch
  • University of Texas Health Science Center at Houston
  • University of Melbourne
  • University of Virginia
  • Case Western Reserve University
  • Fred Hutchinson Cancer Research Center
  • The University of Chicago
  • University of Toronto
  • Stanford University
  • Cancer Prevention Institute of California
  • Mayo Clinic Arizona
  • Dartmouth College

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Background Clustering of breast and colorectal cancer has been observed within some families and cannot be explained by chance or known high-risk mutations in major susceptibility genes. Potential shared genetic susceptibility between breast and colorectal cancer, not explained by high-penetrance genes, has been postulated. We hypothesized that yet undiscovered genetic variants predispose to a breast-colorectal cancer phenotype. Methods To identify variants associated with a breast-colorectal cancer phenotype, we analyzed genome-wide association study (GWAS) data from cases and controls that met the following criteria: cases (n = 985) were women with breast cancer who had one or more first- or second-degree relatives with colorectal cancer, men/women with colorectal cancer who had one or more first- or second-degree relatives with breast cancer, and women diagnosed with both breast and colorectal cancer. Controls (n = 1769), were unrelated, breast and colorectal cancer-free, and age- and sex- frequency-matched to cases. After imputation, 6,220,060 variants were analyzed using the discovery set and variants associated with the breast-colorectal cancer phenotype at P<5.0E-04 (n = 549, at 60 loci) were analyzed for replication (n = 293 cases and 2,103 controls). Results Multiple correlated SNPs in intron 1 of the ROBO1 gene were suggestively associated with the breast-colorectal cancer phenotype in the discovery and replication data (most significant; rs7430339, Pdiscovery = 1.2E-04; rs7429100, Preplication = 2.8E-03). In meta-analysis of the discovery and replication data, the most significant association remained at rs7429100 (P = 1.84E-06). Conclusion The results of this exploratory analysis did not find clear evidence for a susceptibility locus with a pleiotropic effect on hereditary breast and colorectal cancer risk, although the suggestive association of genetic variation in the region of ROBO1, a potential tumor suppressor gene, merits further investigation.

Original languageEnglish
Article numbere0196245
JournalPLOS ONE
Volume13
Issue number4
DOIs
StatePublished - Apr 2018

Fingerprint

Dive into the research topics of 'Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies'. Together they form a unique fingerprint.

Cite this